Your browser doesn't support javascript.
loading
Ustekinumab serum concentrations are associated with clinical outcomes in Crohn's disease - a regional multi-center pilot study.
Thomann, Anne Kerstin; Schulte, Lucas-Alexander; Globig, Anna-Maria; Hoffmann, Peter; Klag, Thomas; Itzel, Timo; Teufel, Andreas; Schreiner, Rupert; Scheffe, Nina; Ebert, Matthias Philip; Wehkamp, Jan; Gauss, Annika; Hasselblatt, Peter; Klaus, Jochen; Reindl, Wolfgang.
Afiliação
  • Thomann AK; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Schulte LA; Department of Medicine I, University Hospital Ulm, Ulm, Germany.
  • Globig AM; Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Hoffmann P; Department of Gastroenterology and Hepatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Klag T; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.
  • Itzel T; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Teufel A; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Schreiner R; Medical Care Center Dr. Limbach and Colleagues, Heidelberg, Germany.
  • Scheffe N; Medical Care Center Dr. Limbach and Colleagues, Heidelberg, Germany.
  • Ebert MP; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
  • Wehkamp J; Department of Internal Medicine I, University Hospital Tübingen, Tübingen, Germany.
  • Gauss A; Department of Gastroenterology and Hepatology, University Hospital Heidelberg, Heidelberg, Germany.
  • Hasselblatt P; Department of Medicine II, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Germany.
  • Klaus J; Department of Medicine I, University Hospital Ulm, Ulm, Germany.
  • Reindl W; Department of Medicine II, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Z Gastroenterol ; 58(5): 439-444, 2020 May.
Article em En | MEDLINE | ID: mdl-32045954
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Crohn / Fármacos Dermatológicos / Ustekinumab / Fatores Imunológicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Z Gastroenterol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Crohn / Fármacos Dermatológicos / Ustekinumab / Fatores Imunológicos Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Z Gastroenterol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Alemanha